Metastatic large cell neuroendocrine carcinoma of larynx: Individualizing tumor biology by dual tracer positron emission tomography/computed tomography (⁶⁸Ga-DOTATATE and ¹⁸F-fluorodeoxyglucose) molecular imaging and disease stabilization following ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy after initial progression on chemoradiotherapy

Abstract

Debate exists on the disease biology and course of primary large cell neuroendocrine carcinoma (LCNEC) of larynx, being classified as a variant of atypical carcinoid by the World Health Organisation-2005 classification, while literature of its aggressive behavior indicating poorly differentiated neuroendocrine carcinoma (akin to pulmonary LCNEC) exists. The utility of dual tracer positron emission tomography/computed tomography (⁶⁸Ga-DOTATATE and ¹⁸F-fluorodeoxyglucose) in deciphering the dynamic tumor biology and feasibility of peptide receptor radionuclide therapy (PRRT) is illustrated in metastatic LCNEC of epiglottis after disease progression following conventional chemoradiotherapy. Relatively, atypical sites of soft-tissue metastases (subcutaneous tissue of arm, scrotal sac, peritoneum, and lamina of thyroid cartilage) and xiphisternum and disease stabilization following ¹⁷⁷Lu-DOTATATE PRRT were other noteworthy unique aspects of this report.

Keywords

¹⁷⁷Lu-DOTATATE - ¹⁸F-fluorodeoxyglucose - ⁶⁸Ga-DOTATATE - carcinoma larynx - dual tracer positron emission tomography-computed tomography - large cell neuroendocrine carcinoma - peptide receptor radionuclide therapy

• References

• 1 Ferlito A, Silver CE, Bradford CR, Rinaldo A. Neuroendocrine neoplasms of the larynx: An overview. Head Neck 2009;31:1634-46.
• 2 Barnes EL, Eveson JW, Reichart P, Sidransky D, editors. Pathology and Genetics of Head and Neck Tumours. In: Kleihues P, Sobin LH, editors. World Health Organization Classification of Tumours. Lyon: IARC Press; 2005.
• 3 Lewis JS Jr., Spence DC, Chiosea S, Barnes EL Jr., Brandwein-Gensler M, El-Mofty SK, et al. Large cell neuroendocrine carcinoma of the larynx: Definition of an entity. Head Neck Pathol 2010;4:198-207.
• 4 van der Laan TP, Plaat BE, van der Laan BF, Halmos GB. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases. Head Neck 2015;37:707-15.
• 5 Maithrea N, Ewe S, Pua KC, Mohamad I. Primary large cell neuroendocrine carcinoma of the larynx. Egypt J Ear Nose Throat Allied Sci 2017;18:179-81.